07:51 AM EDT, 10/07/2025 (MT Newswires) -- Novavax ( NVAX ) said Tuesday it completed the transfer of the marketing authorization for its Nuvaxovid COVID-19 vaccine to Sanofi ( SNY ) in the European Union.

The move allows Sanofi ( SNY ) to take full responsibility for commercial and regulatory activities in the bloc.

Novavax ( NVAX ) said the transfer triggered a $25 million milestone payment to the company and that it is eligible to receive additional future milestones and royalties under the collaboration and license agreement between the two companies.

Novavax ( NVAX ) shares were up 1% in recent premarket activity.